Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A NOVAVAX INC Filed by: BANK OF AMERICA CORP /DE/

April 27, 2026 1:03 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 162,935,945 outstanding shares disclosed in the Form 10-K by the issuer on February 26, 2026, which reports share totals as of February 16, 2026.


SCHEDULE 13G



BANK OF AMERICA CORP /DE/
Signature:/s/ Monica Yako
Name/Title:Authorized Signatory
Date:04/27/2026

ATTACHMENTS / EXHIBITS

POWER OF ATTORNEY

Categories

SEC Filings